NCT06385236 Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping Status RECRUITING Phase PHASE4
NCT06369467 Short-Term Linvoseltamab Treatment on Top of Chronic Dupilumab Treatment for Adults With Severe Immunoglobulin E (IgE)-Mediated Food Allergy Status RECRUITING Phase PHASE1
NCT06352073 Dupilumab for Eosinophilic Esophagitis With Severe Strictures Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT06293053 A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With Prurigo Nodularis Status RECRUITING Phase PHASE3
NCT06226610 Dupixent in Adults With Refractory Post-Burn Pruritus in an Ambulatory Clinic Status RECRUITING Phase PHASE2
NCT06192563 A Study to Observe How Adolescent Patients With Severe Atopic Dermatitis Despite Less Extensive Skin Lesions (Eczema Area and Severity Index Score < 16) Respond to Dupilumab Treatment Status RECRUITING Phase N/A
NCT06191315 Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS) Status RECRUITING Phase PHASE3
NCT06169527 A Long-term Data Collection Study of Participants in France Aged 6 Years Old or More With Atopic Dermatitis Receiving Dupilumab Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06101095 A Study Assessing Esophageal Function and Remodeling With Dupilumab Compared With Placebo for 24 Weeks Followed by 104 Weeks Open Label in Adult Participants With EoE (REMOdeling With Dupilumab in Eosinophilic Esophagitis Long-term Trial) Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT06088771 Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC Status RECRUITING Phase PHASE1/PHASE2
NCT06012448 The Immunologic Effects of Dupilumab in the Treatment of Dermal Hypersensitivity Reaction Status COMPLETED Phase PHASE4
NCT06004986 DUPIlumab Dose REDUCtion in Patients With Controlled Atopic Eczema Status RECRUITING Phase PHASE4
NCT05991323 Real-World Effectiveness of Dupilumab in Patients With Prurigo Nodularis: An Observational Study Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05983068 A Study of Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric Participants With Atopic Dermatitis Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT05942222 A Real-world, Head-to-head Comparison of Dupilumab Versus Mepolizumab in Danish Patients With Chronic Rhinosinusitis With Nasal Polyps Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT05906706 Compassionate Use of Dupilumab for Adult Patients With Bullous Pemphigoid Status APPROVED_FOR_MARKETING Phase N/A